Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
16.12
-0.02 (-0.12%)
Nov 21, 2024, 4:00 PM EST - Market closed

Pulse Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
--0.71.42--
Upgrade
Revenue Growth (YoY)
---50.63%---
Upgrade
Cost of Revenue
--11.941.97--
Upgrade
Gross Profit
---11.24-0.55--
Upgrade
Selling, General & Admin
19.0615.7825.9733.8223.5222.99
Upgrade
Research & Development
29.4727.820.8428.6426.4424.96
Upgrade
Operating Expenses
48.5343.5746.8162.4649.9747.95
Upgrade
Operating Income
-48.53-43.57-58.06-63.01-49.97-47.95
Upgrade
Interest Expense
-1.1-1.1-0.9-0.7--
Upgrade
Interest & Investment Income
3.512.480.640.050.230.98
Upgrade
EBT Excluding Unusual Items
-46.12-42.2-58.32-63.66-49.73-46.97
Upgrade
Gain (Loss) on Sale of Assets
-0.01-0.01-0.19--0.12-
Upgrade
Pretax Income
-46.13-42.21-58.51-63.66-49.85-46.97
Upgrade
Net Income
-46.13-42.21-58.51-63.66-49.85-46.97
Upgrade
Net Income to Common
-46.13-42.21-58.51-63.66-49.85-46.97
Upgrade
Shares Outstanding (Basic)
554834282321
Upgrade
Shares Outstanding (Diluted)
554834282321
Upgrade
Shares Change (YoY)
23.82%41.56%21.35%20.29%12.06%21.48%
Upgrade
EPS (Basic)
-0.83-0.88-1.72-2.28-2.14-2.26
Upgrade
EPS (Diluted)
-0.83-0.88-1.72-2.28-2.14-2.26
Upgrade
Free Cash Flow
-34.1-33.16-47.41-54.53-35.81-34.79
Upgrade
Free Cash Flow Per Share
-0.61-0.69-1.40-1.95-1.54-1.68
Upgrade
Gross Margin
----38.79%--
Upgrade
Operating Margin
---8293.86%-4443.86%--
Upgrade
Profit Margin
---8357.86%-4489.42%--
Upgrade
Free Cash Flow Margin
---6773.43%-3845.84%--
Upgrade
EBITDA
-47.33-42.37-56.7-61.87-48.87-46.79
Upgrade
D&A For EBITDA
1.21.211.361.151.11.16
Upgrade
EBIT
-48.53-43.57-58.06-63.01-49.97-47.95
Upgrade
Revenue as Reported
--0.71.42--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.